BioDelivery Sciences International (FRA:BD5) EV-to-Revenue : 3.33 (As of May. 28, 2024)

BioDelivery Sciences International EV-to-Revenue Chart

BioDelivery Sciences International Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EV-to-Revenue		Get a 7-Day Free Trial					3.09	4.85	5.41	2.51	1.56

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
EV-to-Revenue	Get a 7-Day Free Trial															2.51	2.22	1.90	1.90	1.56

Competitive Comparison of BioDelivery Sciences International's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioDelivery Sciences International's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's EV-to-Revenue falls into.

BioDelivery Sciences International EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioDelivery Sciences International's EV-to-Revenue for today is calculated as:

BioDelivery Sciences International's current Enterprise Value is €472.9 Mil.
BioDelivery Sciences International's Revenue for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €142.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International  (FRA:BD5) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioDelivery Sciences International's PS Ratiofor today is calculated as:

BioDelivery Sciences International's share price for today is €5.05.
BioDelivery Sciences International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.38.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioDelivery Sciences International EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description